Novel clinical therapeutics targeting the epithelial to mesenchymal transition

Area of Science:

• Cell Biology
• Developmental Biology
• Oncology

Background:

• The epithelial to mesenchymal transition (EMT) is a fundamental biological process involved in development and disease.
• EMT plays a critical role in cancer progression, including metastasis.
• Understanding EMT mechanisms is key to developing new therapeutic interventions.

Purpose of the Study:

• To review the dual role of EMT in development and disease.
• To highlight conserved EMT pathways as targets for drug development.
• To discuss the influence of the tumor microenvironment on EMT in cancer.

Main Methods:

• Literature review focusing on EMT mechanisms and therapeutic targets.
• Analysis of conserved pathways in developmental and pathological EMT.
• Examination of the tumor microenvironment's role in modulating EMT.
• Overview of current and emerging clinical therapies targeting EMT.

Main Results:

• EMT is essential for both normal development and pathological conditions like cancer metastasis.
• Similar molecular pathways are utilized in developmental and pathological EMT, presenting therapeutic opportunities.
• The tumor microenvironment significantly influences EMT progression and metastasis.
• Various therapeutic strategies, including small molecule inhibitors and RNA-based therapies, are being developed.

Conclusions:

• Targeting EMT pathways holds significant promise for novel therapeutic development in cancer and other diseases.
• Further research into EMT regulation and the tumor microenvironment can lead to more effective treatments.
• Clinical trials are evaluating diverse therapeutic approaches to inhibit pathological EMT.